Search Results - "The lancet HIV"
-
1
Potential effects of disruption to HIV programmes in sub-Saharan Africa caused by COVID-19: results from multiple mathematical models
Published in The lancet HIV (01-09-2020)“…The COVID-19 pandemic could lead to disruptions to provision of HIV services for people living with HIV and those at risk of acquiring HIV in sub-Saharan…”
Get full text
Journal Article -
2
Description of COVID-19 in HIV-infected individuals: a single-centre, prospective cohort
Published in The lancet HIV (01-08-2020)“…Information about incidence, clinical characteristics, and outcomes of HIV-infected individuals with severe acute respiratory syndrome coronavirus 2…”
Get full text
Journal Article -
3
HIV infection and COVID-19 death: a population-based cohort analysis of UK primary care data and linked national death registrations within the OpenSAFELY platform
Published in The lancet HIV (01-01-2021)“…Whether HIV infection is associated with risk of death due to COVID-19 is unclear. We aimed to investigate this association in a large-scale population-based…”
Get full text
Journal Article -
4
Maintaining HIV care during the COVID-19 pandemic
Published in The lancet HIV (01-05-2020)Get full text
Journal Article -
5
Global, regional, and national incidence, prevalence, and mortality of HIV, 1980–2017, and forecasts to 2030, for 195 countries and territories: a systematic analysis for the Global Burden of Diseases, Injuries, and Risk Factors Study 2017
Published in The lancet HIV (01-12-2019)“…Understanding the patterns of HIV/AIDS epidemics is crucial to tracking and monitoring the progress of prevention and control efforts in countries. We provide…”
Get full text
Journal Article -
6
COVID-19 in patients with HIV: clinical case series
Published in The lancet HIV (01-05-2020)Get full text
Journal Article -
7
Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: an observational cohort study
Published in The lancet HIV (01-09-2017)“…Data for on-demand pre-exposure prophylaxis (PrEP) are scarce. We implemented a cohort study to assess its efficacy, safety, and effect on sexual behaviour. We…”
Get full text
Journal Article -
8
Cancer risk in HIV-infected people in the USA from 1996 to 2012: a population-based, registry-linkage study
Published in The lancet HIV (01-11-2017)“…Monitoring cancer risk among HIV-infected people in the modern antiretroviral therapy (ART) era is essential given their elevated risk for many cancers and…”
Get full text
Journal Article -
9
Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies
Published in The lancet HIV (01-08-2017)“…Summary Background Health care for people living with HIV has improved substantially in the past two decades. Robust estimates of how these improvements have…”
Get full text
Journal Article -
10
The impact of the COVID-19 lockdown on HIV care in 65 South African primary care clinics: an interrupted time series analysis
Published in The lancet HIV (01-03-2021)“…The effect of the COVID-19 pandemic on HIV outcomes in low-income and middle-income countries is poorly described. We aimed to measure the impact of the 2020…”
Get full text
Journal Article -
11
Stigma reduction interventions in people living with HIV to improve health-related quality of life
Published in The lancet HIV (01-02-2020)“…As the UNAIDS 90-90-90 targets for people living with HIV are increasingly being reached in many contexts, health-related quality of life, the so-called fourth…”
Get full text
Journal Article -
12
Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trial
Published in The lancet HIV (01-08-2021)“…Data on vaccine immunogenicity against SARS-CoV-2 are needed for the 40 million people globally living with HIV who might have less functional immunity and…”
Get full text
Journal Article -
13
Overview of SARS-CoV-2 infection in adults living with HIV
Published in The lancet HIV (01-05-2021)“…Around 2·5 million deaths and more than 110 million COVID-19 cases have been reported globally. Although it initially appeared that HIV infection was not a…”
Get full text
Journal Article -
14
Life expectancy after 2015 of adults with HIV on long-term antiretroviral therapy in Europe and North America: a collaborative analysis of cohort studies
Published in The lancet HIV (01-05-2023)“…The life expectancy of people with HIV taking antiretroviral therapy (ART) has increased substantially over the past 25 years. Most previous studies of life…”
Get full text
Journal Article -
15
Viral suppression and HIV transmission in serodiscordant male couples: an international, prospective, observational, cohort study
Published in The lancet HIV (01-08-2018)“…Evidence on viral load and HIV transmission risk in HIV-serodiscordant male homosexual couples is limited to one published study. We calculated transmission…”
Get full text
Journal Article -
16
HIV and cardiovascular disease
Published in The lancet HIV (01-04-2020)“…HIV-related cardiovascular disease research is predominantly from Europe and North America. Of the estimated 37·9 million people living with HIV worldwide,…”
Get full text
Journal Article -
17
Discontinuation, suboptimal adherence, and reinitiation of oral HIV pre-exposure prophylaxis: a global systematic review and meta-analysis
Published in The lancet HIV (01-04-2022)“…Poor adherence to oral HIV pre-exposure prophylaxis (PrEP) diminishes its clinical and public health benefits. This study synthesises evidence regarding…”
Get full text
Journal Article -
18
Population-level effectiveness of rapid, targeted, high-coverage roll-out of HIV pre-exposure prophylaxis in men who have sex with men: the EPIC-NSW prospective cohort study
Published in The lancet HIV (01-11-2018)“…HIV pre-exposure prophylaxis (PrEP) is highly effective in men who have sex with men (MSM) at the individual level, but data on population-level impact are…”
Get full text
Journal Article -
19
Dolutegravir with emtricitabine and tenofovir alafenamide or tenofovir disoproxil fumarate versus efavirenz, emtricitabine, and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection (ADVANCE): week 96 results from a randomised, phase 3, non-inferiority trial
Published in The lancet HIV (01-10-2020)Get full text
Journal Article -
20
Clinical features of, and risk factors for, severe or fatal COVID-19 among people living with HIV admitted to hospital: analysis of data from the WHO Global Clinical Platform of COVID-19
Published in The lancet HIV (01-07-2022)“…WHO has established a Global Clinical Platform for the clinical characterisation of COVID-19 among hospitalised individuals. We assessed whether people living…”
Get full text
Journal Article